Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] NODDI in clinical research
Diffusion MRI (dMRI) has proven to be a useful imaging approach for both clinical diagnosis
and research investigating the microstructures of nervous tissues, and it has helped us to …
and research investigating the microstructures of nervous tissues, and it has helped us to …
Systematic review: quantitative susceptibility map** (QSM) of brain iron profile in neurodegenerative diseases
Iron has been increasingly implicated in the pathology of neurodegenerative diseases. In
the past decade, development of the new magnetic resonance imaging technique …
the past decade, development of the new magnetic resonance imaging technique …
CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease
A Southon, K Szostak, KM Acevedo… - British journal of …, 2020 - Wiley Online Library
Background and Purpose Diacetyl‐bis (4‐methyl‐3‐thiosemicarbazonato) copperII (CuII
(atsm)) ameliorates neurodegeneration and delays disease progression in mouse models of …
(atsm)) ameliorates neurodegeneration and delays disease progression in mouse models of …
MRI biomarkers for memory-related impairment in amyotrophic lateral sclerosis: a systematic review
Introduction Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder associated
with cognitive and behavioral impairments and motor symptoms. Magnetic resonance …
with cognitive and behavioral impairments and motor symptoms. Magnetic resonance …
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disorder with
complex biology and significant clinical heterogeneity. Many preclinical and early phase …
complex biology and significant clinical heterogeneity. Many preclinical and early phase …
Diagnostics of amyotrophic lateral sclerosis: up to date
I Štětkářová, E Ehler - Diagnostics, 2021 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
characterized by gradual loss of upper and lower motor neurons and their pathways, usually …
characterized by gradual loss of upper and lower motor neurons and their pathways, usually …
Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS
Amyotrophic lateral sclerosis (ALS) encompasses a heterogeneous group of phenotypes
with different progression rates, varying degree of extra-motor involvement and divergent …
with different progression rates, varying degree of extra-motor involvement and divergent …
Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics
Background Amyotrophic lateral sclerosis (ALS) a highly heterogeneous neurodegenerative
condition. Accurate diagnostic, monitoring and prognostic biomarkers are urgently needed …
condition. Accurate diagnostic, monitoring and prognostic biomarkers are urgently needed …
Focus on the heterogeneity of amyotrophic lateral sclerosis
C Bendotti, V Bonetto, E Pupillo… - … Lateral Sclerosis and …, 2020 - Taylor & Francis
The clinical manifestations of amyotrophic lateral sclerosis (ALS) are variable in terms of age
at disease onset, site of onset, progression of symptoms, motor neuron involvement, and the …
at disease onset, site of onset, progression of symptoms, motor neuron involvement, and the …
Structural magnetic resonance imaging findings and histopathological correlations in motor neuron diseases—A systematic review and meta-analysis
C Zejlon, D Nakhostin, S Winklhofer, A Pangalu… - Frontiers in …, 2022 - frontiersin.org
Objectives The lack of systematic evidence on neuroimaging findings in motor neuron
diseases (MND) hampers the diagnostic utility of magnetic resonance imaging (MRI). Thus …
diseases (MND) hampers the diagnostic utility of magnetic resonance imaging (MRI). Thus …